Bayer Aktie News

Germany's Bayer said on Wednesday that its supervisory board had extended the contract of CEO Bill Anderson until March 31, 2029.

Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside. The main risks are ongoing glyphosate litigation and pharma pricing pressures, but current valuation heavily discounts these concerns. Despite crop science headwinds and legacy litigation, core pharma brands and pipeline growth provide a foundation for recovery.

Beim Umbau des Agrarchemie- und Pharmakonzerns Bayer DE000BAY0017 bekommt der Vorstandsvorsitzende Bill Anderson mehr Zeit.

Eine neue Medikamentenzulassung in den USA hat den Aktien von Bayer DE000BAY0017 am Montag in einem schwachen Gesamtmarkt Auftrieb gegeben.

Bayer DE000BAY0017 darf das Medikament Finerenon in den USA nun auch gegen eine bestimmte Form der Herzinsuffizienz vermarkten.

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased by an experimental non-hormonal drug being developed by Bayer , according to results from a late-stage trial.

ST. LOUIS--(BUSINESS WIRE)--Bayer today announced the appointment of Priyal Patel as Cluster Chief Financial Officer (CFO) for North America, effective July 1, 2025. In her new role, Patel will oversee financial strategy and operations across Bayer's North American businesses while continuing to serve as Head of Treasury for Bayer North America. She succeeds Guru Ramamurthy, who was recently ap...

The U.S. Supreme Court asked President Donald Trump's administration on Monday for its views on Bayer's bid to sharply limit lawsuits claiming that the company's Roundup weedkiller causes cancer and potentially avert billions of dollars in damages.